Pfizer reported Tuesday a loss following a sharp fall in the sales of its Covid-19 vaccine and therapeutic from pandemic peaks.
Pfizer reported Tuesday a loss following a sharp fall in the sales of its Covid-19 vaccine and therapeutic from pandemic peaks. The drugmaker reported a third-quarter loss of $2.4 billion, compared with $8.6 billion in profits in the year-ago period. Results were dented by a $5.6 billion inventory write-down in Covid-19 therapeutic Paxlovid and vaccine […]
The post Pfizer reports loss as Covid-19 revenues shrink appeared first on Insider Paper.
https://insiderpaper.com/pfizer-reports-loss-as-covid-19-revenues-shrink/
Comments
0 comment